Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioChaperone Human Insulin PK/PD Clamp Study in T1D
NCT02213146Phase 2Completed
- Sponsor
- Adocia
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of biochaperone human insulin in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Adocia. Primary endpoint: Area under the insulin concentration-time curve from 0 to 1 hour. Started Aug 2014; status: completed.
02
Drugs
biochaperone human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02213146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213146.